| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0014 | 1 |